Fischer Medical Ventures board has announced the financial results for the quarter and half-year, with H1 consolidated profit at Rs 18.90 Cr. It also approved Mr. Chan Sing En as Independent Director and proposed Dr. Syed Jalaludin's appointment, pending shareholder vote.